Raymond K Cross (Raymond Cross)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 35

Top Topics

Patients With Inflammatory Bowel Disease

Top Venues

The American journal of gastroenterology

Inflammatory bowel diseases

JMIR research protocols

Crohn's & colitis 360

This page only lists publications with an associated author ORCID identifier.

Publications

Himanshi Tanwar, Jeba Mercy Gnanasekaran, Devon Allison, Ling-Shiang Chuang, Xuesong He, Mario Aimetti, Giacomo Baima, Massimo Costalonga, Raymond K Cross, Cynthia Sears, Saurabh Mehandru, Judy Cho, Jean-Frederic Colombel, Jean-Pierre Raufman, Vivek Thumbigere-Math
Unraveling the Oral-Gut axis: Interconnection between Periodontitis and IBD, Current Challenges, and Future Perspective. Journal of Crohn's & colitis (2024)
Himanshi Tanwar, Jeba Mercy Gnanasekaran, Devon Allison, Ling-Shiang Chuang, Xuesong He, Mario Aimetti, Giacomo Baima, Massimo Costalonga, Raymond K Cross, Cynthia Sears, Saurabh Mehandru, Judy Cho, Jean-Frederic Colombel, Jean-Pierre Raufman, Vivek Thumbigere-Math
Unravelling the Oral-Gut Axis: Interconnection Between Periodontitis and Inflammatory Bowel Disease, Current Challenges, and Future Perspective. Journal of Crohn's & colitis 18 (8) (2024)
Himanshi Tanwar, Jeba Mercy Gnanasekaran, Devon Allison, Ling-Shiang Chuang, Xuesong He, Mario Aimetti, Giacomo Baima, Massimo Costalonga, Raymond K Cross, Cynthia Sears, Saurabh Mehandru, Judy Cho, Jean-Frederic Colombel, Jean-Pierre Raufman, Vivek Thumbigere-Math
Unravelling the Oral-Gut Axis: Interconnection Between Periodontitis and Inflammatory Bowel Disease, Current Challenges, and Future Perspective. Journal of Crohn's & colitis 18 (8) (2024)
Cassandra A Cairns, Raymond K Cross, Mariam Khambaty, Andrea C Bafford
Monitoring Patients with Inflammatory Bowel Disease at High Risk of Anal Cancer. The American journal of gastroenterology (2023)
Madeline Alizadeh, Osman Ali, Raymond K Cross
Assessing Progression of Biologic Therapies Based on Smoking Status in Patients With Crohn's Disease. Inflammatory bowel diseases (2023)
Seema A Patil, Raymond K Cross
Nothing Compares to U-padacitinib. The American journal of gastroenterology (2023)
Jordan E Axelrad, Raymond K Cross
Surveillance for Colorectal Neoplasia in Inflammatory Bowel Disease: When to Stop. The American journal of gastroenterology (2023)
Lauren A George, Harris T Feldman, Madeline Alizadeh, Ameer Abutaleb, Samantha Zullow, Ashley Hine, Kristen Stashek, Suparna Sarkar, Katherine Sun, David Hudesman, Jordan E Axelrad, Raymond K Cross
Histologic Inflammation can Predict Future Clinical Relapse in Ulcerative Colitis Patients in Endoscopic Remission. Crohn's & colitis 360 5 (4) (2023)
Maia Kayal, Parakkal Deepak, Poonam Beniwal-Patel, Laura Raffals, Marla C Dubinsky, Shannon Chang, Peter D R Higgins, Yue Jiang, Raymond K Cross, Millie D Long, Hans H Herfarth, Edward L Barnes
Changes in Therapy Are Not Associated with Increased Remission in Patients with Crohn's Disease of the Pouch. The American journal of gastroenterology (2023)
Jordan E Axelrad, Raymond K Cross
Surveillance for Colorectal Neoplasia in Inflammatory Bowel Disease: When to Stop. The American journal of gastroenterology (2023)
Libby Wei, Seema A Patil, Raymond K Cross, Kenneth J Taubenslag, Lisa S Schocket
Cystoid macular edema after initiation of ozanimod for ulcerative colitis. The American journal of gastroenterology (2023)
Jordan E Axelrad, Raymond K Cross
Surveillance for Colorectal Neoplasia in Inflammatory Bowel Disease: When to Stop. The American journal of gastroenterology 118 (3) (2022)
Yaara Zisman-Ilani, Kimberly D Thompson, Lori S Siegel, Todd Mackenzie, Damara J Crate, Joshua R Korzenik, Gil Y Melmed, Patricia Kozuch, Bruce E Sands, David T Rubin, Miguel D Regueiro, Raymond K Cross, Douglas C Wolf, John S Hanson, Ronald M Schwartz, Raluca Vrabie, Michael D Kreines, Timothy Scherer, Marla C Dubinsky, Corey A Siegel
Crohn's disease shared decision making intervention leads to more patients choosing combination therapy: a cluster randomised controlled trial. Alimentary pharmacology & therapeutics (2022)
Jordan E Axelrad, Raymond K Cross
Surveillance for Colorectal Neoplasia in Inflammatory Bowel Disease: When to Stop. The American journal of gastroenterology 118 (3) (2022)
James D Lewis, Raymond K Cross, Millie Long, Siddharth Singh, Hans H Herfarth, Alexandra Weiss, Anna Buchner
High Degree of Practice Variability in Colonic Dysplasia Surveillance for Patients With Inflammatory Bowel Disease. Inflammatory bowel diseases 28 (8) (2022)
Raymond K Cross, April N Naegeli, Ryan W Harrison, Page C Moore, Rachel H Mackey, Margaux M Crabtree, Celeste A Lemay, Vipin Arora, Nathan Morris, Angelina Sontag, Cem Kayhan, Joshua R Korzenik
Disease Burden and Patient-Reported Outcomes Among Ulcerative Colitis Patients According to Therapy at Enrollment Into CorEvitas' Inflammatory Bowel Disease Registry. Crohn's & colitis 360 4 (3) (2022)
Jordan E Axelrad, Millie D Long, Sara N Horst, Anita Afzali, Tamar Sapir, Kristina Fajardo, Kara De Felice, Robert S Sandler, Raymond K Cross
A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and Persistence With Inflammatory Bowel Disease Therapy (ASSIST Study): Protocol for a Randomized Controlled Trial. JMIR research protocols 11 (12) (2022)
Raymond K Cross, April N Naegeli, Ryan W Harrison, Page C Moore, Rachel H Mackey, Margaux M Crabtree, Celeste A Lemay, Vipin Arora, Nathan Morris, Angelina Sontag, Cem Kayhan, Joshua R Korzenik
Disease Burden and Patient-Reported Outcomes Among Ulcerative Colitis Patients According to Therapy at Enrollment Into CorEvitas' Inflammatory Bowel Disease Registry. Crohn's & colitis 360 4 (3) (2022)
Jordan E Axelrad, Millie D Long, Sara N Horst, Anita Afzali, Tamar Sapir, Kristina Fajardo, Kara De Felice, Robert S Sandler, Raymond K Cross
A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and Persistence With Inflammatory Bowel Disease Therapy (ASSIST Study): Protocol for a Randomized Controlled Trial. JMIR research protocols 11 (12) (2022)
Jordan E Axelrad, Raymond K Cross
Surveillance for Colorectal Neoplasia in Inflammatory Bowel Disease: When to Stop. The American journal of gastroenterology 118 (3) (2022)
Seema A Patil, Shubha Bhat, Jimmy K Limdi, Francis A Farraye, Raymond K Cross
The Sincerest Form of Flattery? Biosimilars in Inflammatory Bowel Disease. Inflammatory bowel diseases 28 (12) (2022)
Jordan E Axelrad, Millie D Long, Sara N Horst, Anita Afzali, Tamar Sapir, Kristina Fajardo, Kara De Felice, Robert S Sandler, Raymond K Cross
A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and Persistence With Inflammatory Bowel Disease Therapy (ASSIST Study): Protocol for a Randomized Controlled Trial. JMIR research protocols 11 (12) (2022)
Jordan E Axelrad, Millie D Long, Sara N Horst, Anita Afzali, Tamar Sapir, Kristina Fajardo, Kara De Felice, Robert S Sandler, Raymond K Cross
A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and Persistence With Inflammatory Bowel Disease Therapy (ASSIST Study): Protocol for a Randomized Controlled Trial. JMIR research protocols 11 (12) (2022)
Jordan E Axelrad, Millie D Long, Sara N Horst, Anita Afzali, Tamar Sapir, Kristina Fajardo, Kara De Felice, Robert S Sandler, Raymond K Cross
A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and Persistence With Inflammatory Bowel Disease Therapy (ASSIST Study): Protocol for a Randomized Controlled Trial. JMIR research protocols 11 (12) (2022)
Kimberly N Weaver, Xian Zhang, Xiangfeng Dai, Wenli Chen, Runa Watkins, Jeremy Adler, Marla C Dubinsky, Arthur Kastl, Athos Bousvaros, Jennifer A Strople, Raymond K Cross, Peter D R Higgins, Ryan C Ungaro, Meenakshi Bewtra, Emanuelle Bellaguarda, Francis A Farraye, Riley Craig, Cristian Hernandez, Margie E Boccieri, Ann Firestine, Kelly Y Chun, Millie D Long, Michael D Kappelman
Low Rates of Breakthrough COVID-19 Infection After SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease. Inflammatory bowel diseases (2022)
Aakash Desai, Parakkal Deepak, Raymond K Cross, Julie Murone, Francis A Farraye, Ryan C Ungaro, Gursimran S Kochhar
Effect of 2 vs 3 Doses of COVID-19 Vaccine in Patients With Inflammatory Bowel Disease: A Population-based Propensity Matched Analysis. Inflammatory bowel diseases (2022)
Laura E Raffals, Sumona Saha, Meenakshi Bewtra, Cecile Norris, Angela Dobes, Caren Heller, Sirimon O'Charoen, Tara Fehlmann, Sara Sweeney, Alandra Weaver, Shrinivas Bishu, Raymond K Cross, Themistocles Dassopoulos, Monika Fischer, Andres Yarur, David Hudesman, Deepak Parakkal, Richard Duerr, Freddy Caldera, Joshua Korzenik, Joel Pekow, Katerina Wells, Matthew Bohm, Lilani Perera, Manreet Kaur, Matthew Ciorba, Scott Snapper, Elizabeth A Scoville, Sushila Dalal, Uni Wong, James D Lewis
The Development and Initial Findings of A Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD). Inflammatory bowel diseases (2021)
Kimberly N Weaver, Xian Zhang, Xiangfeng Dai, Runa Watkins, Jeremy Adler, Marla C Dubinsky, Arthur Kastl, Athos Bousvaros, Jennifer A Strople, Raymond K Cross, Peter D R Higgins, Ryan C Ungaro, Meenakshi Bewtra, Emanuelle Bellaguarda, Francis A Farraye, Margie E Boccieri, Ann Firestine, Michael D Kappelman, Millie D Long
Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID. Inflammatory bowel diseases (2021)
Dania Hudhud, Freddy Caldera, Raymond K Cross
Addressing COVID-19 Vaccine Hesitancy in Patients with IBD. Inflammatory bowel diseases (2021)
Natasha Kamal, Kiran Motwani, Jennifer Wellington, Uni Wong, Raymond K Cross
Fecal Incontinence in Inflammatory Bowel Disease. Crohn's & colitis 360 3 (2) (2021)
Sumona Bhattacharya, Gianna Stoleru, Preet Patel, Ameer Abutaleb, Kristen Stashek, Raymond K Cross
Characterization of Mycophenolate Mofetil Gastrointestinal Toxicity and Risk Factors for Severe Disease and Poor Prognosis. Inflammatory bowel diseases (2021)
Lauren A George, Raymond K Cross
Remote Monitoring and Telemedicine in IBD: Are We There Yet? Current gastroenterology reports 22 (3) (2020)
Byron P Vaughn, Andres J Yarur, Elliot Graziano, James P Campbell, Abhik Bhattacharya, Jennifer Y Lee, Katherine Gheysens, Konstantinos Papamichael, Mark T Osterman, Adam S Cheifetz, Raymond K Cross
Vedolizumab Serum Trough Concentrations and Response to Dose Escalation in Inflammatory Bowel Disease. Journal of clinical medicine 9 (10) (2020)
Charlene Connolly Quinn, Sarah Chard, Erin G Roth, J Kevin Eckert, Katharine M Russman, Raymond K Cross
The Telemedicine for Patients With Inflammatory Bowel Disease (TELE-IBD) Clinical Trial: Qualitative Assessment of Participants' Perceptions. Journal of medical Internet research 21 (6) (2019)
Raymond K Cross, Michael Chiorean, Francis Vekeman, Yongling Xiao, Eric Wu, Jingdong Chao, Anthony W Wang
Assessment of the real-world safety profile of vedolizumab using the United States Food and Drug Administration adverse event reporting system. PloS one 14 (12) (2019)